2021 UCI Innovator Awards Virtual Reception

Photo by: UCI Beall Applied Innovation

Our faculty member Dr. Anand Ganesan is nominated as a UCI Beall Applied Innovation 2021 Innovator Award Nominee in The Emerging Innovation/Early Career Innovator of the Year Award!
UCI Beall Applied Innovation, with generous support from Don and Ken Beall, created the annual UCI Innovator Awards to recognize UCI researchers working actively to promote commercialization of university intellectual property, which supports industry growth and moves inventions from the lab to market to benefit humankind.
Join us on October 19 from 1-2 p.m. PT to hear who amongst the many talented nominees will take home awards.

The Emerging Innovation/Early Career Innovator of the Year Award

Anand Ganesan, M.D. Ph.D.
Professor
School of Medicine

Han Li, Ph.D.
Associate Professor
Henry Samueli School of Engineering

Iryna Zenyuk, Ph. D.
Associate Professor
Henry Samueli School of Engineering

Click here to view the full award list on the UCI Beall Applied Innovation website.

Gratton Receives Award for Pioneering Work

The International Society for Optics and Photonics (SPIE) recognized ENRICO GRATTON with the 2021 Britton Chance Biomedical Optics Award at the SPIE Photonics West virtual conference. The award cited Gratton’s significant contributions to biophotonics – the science of producing and utilizing photons or light to image, identify and engineer biological materials. SPIE specifically noted his development of innovative ultrafast optical imaging and spectroscopy methods and their integration into microfluidic platforms.

This award was “a great honor” for Gratton who considers Chance, for whom the award was named, a “great friend.” In his conference presentation, Gratton shared his experiences meeting Chance, a National Academy of Sciences member and Olympic gold medalist in sailing who died in 2010, and doing research together.

Gratton is a professor of biomedical engineering and principal investigator for UCI’s Laboratory for Fluorescence Dynamics. A pioneer in the field of biomedical optics, Gratton’s achievements include development of the following technologies: multifrequency phase fluorometry, pulsed-source methods for frequency-domain fluorescence spectroscopy, generalized polarization to study cell membranes, spectral fluorescence lifetime measurements for cell physiology, photo-density waves, quantitative tissue oximetry with near-infrared spectroscopy and optical brain imaging.

During his more than 40-year career, Gratton has disseminated his work to researchers worldwide, trained younger scientists and interfaced successfully with industry. Under his guidance, more than 50 students have earned doctorates, with most currently occupying critical roles in academia and research institutions.

Read full article in UCI Department of Biomedical Engineering Discovery magazine.

Berns Recognized for Biomedical Optics Contributions

MICHAEL BERNS, Distinguished Professor Emeritus of biomedical engineering with a joint appointment in developmental and cell biology, and co-founder and founding director of UCI Beckman Laser Institute & Medical Clinic, has been elected as a Fellow of the Royal Society of Medicine in the United Kingdom.

Berns was invited to join the society based on his extensive biomedical optics contributions in the fields of biology and medicine. “I am truly honored to be invited to join the Royal Society, especially because it’s the same society that has honored so many elite luminaries of the past,” said Berns.

The mission of the organization is to advance health, through education and innovation. Fellows and Foreign Members of the Royal Society of Medicine are elected for life through a peer review process membership and governance. Famous Fellows include Charles Darwin, Louis Pasteur,
Edward Jenner and Sigmund Freud. Elected Fellows of the British Royal Society of Medicine are comparable to members of the National Academy of Medicine in the United States.

Click here to read UCI Department of Biomedical Engineering Discovery magazine.

Botvinick to Develop First-of-its-Kind Diabetes Monitor

Elliot Botvinick, professor of biomedical engineering, has been awarded a three-year, $3.5 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to further the development of an innovative continuous-use monitor for those with Type 1 diabetes. The first-of-its kind device will simultaneously measure insulin, glucose, lactate, oxygen and the ketone body beta-hydroxybutyrate with a single probe inserted just beneath the skin.

Called iGLOBE (Insulin + Glucose + Lactate + Oxygen + Beta-HydroxybutyratE) LifeStrip, the monitor utilizes light and chemistry to provide sensing capabilities for multiple analytes, which can be critical for controlling blood glucose and detecting possible dangerous events. The device will include continuous insulin monitoring and improve dosing efficacy by providing real-time feedback on the dynamics of insulin-pump therapy as well as real-time estimates of a patient’s sensitivity to the insulin.

It is also important to monitor blood glucose in those with Type 1 diabetes, known as insulin dependent diabetes. When blood glucose is elevated above normal values, called hyperglycemia, the body produces a chemical called beta-hydroxybutyrate. Elevated beta-hydroxybutyrate is associated with diabetic ketoacidosis, a dangerous condition, which can result in hospitalization or death. iGLOBE monitors this chemical to indicate dangerous levels and ensure automated insulin delivery functions properly.

Monitoring lactate, produced during exercise, is also important, as it can indicate changing metabolic states, which can lead to changes in blood glucose hours after exercise. This will improve glucose prediction and improve insulin dosing. “Clinical evidence suggests that both beta-hydroxybutyrate and insulin sensing would improve outcomes and decrease the rates of hospitalization, severe morbidity and death associated with hypo- and hyperglycemia,” said Botvinick, who is also associate director of UCI’s Edwards Lifesciences Center for Advanced Cardiovascular Technology and professor of surgery at UCI Beckman Laser Institute (BLI).

The addition of beta-hydroxybutyrate and insulin monitoring capabilities has the potential to be life-altering. “When taken together, glucose, lactate, beta-hydroxybutyrate and insulin monitoring can transform the care of people with Type 1 diabetes,” Botvinick said. “iGLOBE can improve glucose control, compensate for glucose variations associated with exercise, inform of possible or current diabetic ketoacidosis and inform of failing or failed insulin delivery.”

Botvinick is collaborating with Gregory Weiss, UCI professor of chemistry, molecular biology and biochemistry; and David O’Neal, M.D., professor of endocrinology at Australia’s University of Melbourne. The team includes John Weidling, BLI associate project scientist, and biomedical engineering graduate students Toni Wilkinson and Dat Nguyen.

Click here to read UCI Department of Biomedical Engineering Discovery magazine.

7 New Startups Further Their Dreams in Wayfinder Program

By: Jackie Connor

Photo by: Kate Wokowsky

UC Irvine (UCI) Beall Applied Innovation’s Wayfinder incubator recently added seven new startup teams to its roster of more than 60 startups total. In addition to UCI, teams hail from across the University of California’s 10 statewide schools, including UC Berkeley, UC Riverside and UC Santa Barbara.

This new batch of startup teams are working on products and services that range from employee engagement, comedic entertainment, noninvasive devices, interactive crowdfunding and more.

StyloSonic:
Developed by UCI and UC San Diego alumni, StyloSonic is a startup that is creating a noninvasive periodontal imaging device.

Shaka:
Shaka is an employee engagement platform. This startup was also the grand prize winner in the 2021 New Venture Competition taking home $10,000 that will help accelerate their growth. UCI’s Paul Merage School of Business holds the annual competition.

Foodable:
Created by UCI undergraduates, Foodable is a platform that sells excess food at a discounted price to consumers.

Feminora:
Feminora is a startup based on UCI intellectual property that is working on a vaginal speculum that minimizes patient discomfort.

Online Open Mic:
Founded by a graduate from UCI’s Master of Innovation and Entrepreneurship program, Online Open Mic is an entertainment platform that connects comedians and fans.

Grasshopperfund:
Co-founded by UCI undergraduate students, Grasshopperfund is a crowdfunding platform that allows young entrepreneurs to highlight their startups, raise funds and find team members. The team recently placed first in the 11th annual Butterworth Product Development Competition.

Glass Notebook:
Co-founded by UCI undergraduates and alumni, Glass Notebook is a browser-based computational notebook for high-performance computer clusters.

These startups will appear in the Wayfinder program’s Pitch and Match events, which provides new and seasoned startups with a platform to pitch their company, highlight milestones and ask for guidance from community members. Stay tuned to Applied Innovation’s events.

Learn more about the Wayfinder program.

Click here to read the full article on the UCI Beall Applied Innovation website.

2021 Faculty Mentorship Awards

By: UCI School of Medicine

Congratulations to our faculty member Brian Wong for winning Clinical Faculty Mentor of the Year!

Brian Wong, MD, PhD, professor of otolaryngology, for his many years of dedication to mentoring translational and clinical faculty.

Click here to view all 2021 Faculty Mentorship Awards.

Nature Methods Profiles Michelle Digman

She connects equity, samurai swords, imaging and an automated way to count and track mitochondria.

by Vivien Marx / Nature Methods
Photo credit: E. Digman

Aug. 19, 2021 – “My path to faculty was definitely not standard or straight,” says Michelle Digman, who is on the faculty of the Department of Biomedical Engineering at the University of California, Irvine (UCI), where she develops imaging techniques, shapes the department’s policies on equity matters and does outreach programs for local community college and high school students from minorities under-represented in science. She co-directs the Laboratory for Fluorescence Dynamics, directs the W.M. Keck Nanoimaging Laboratory and was recently named an Allen Distinguished Investigator for a bioluminescence imaging project she is working on with UCI colleague Jennifer Prescher.

After obtaining her Ph.D. degree in chemistry at the University of Illinois, Chicago, she was a postdoctoral fellow in the physics lab of Enrico Gratton at the university’s Urbana-Champaign campus. Then she followed Gratton’s move to UCI, where she completed her fellowship. Next, she became scientific director of UCI’s optical core. “I like helping people,” she says.

After a few years, though, she missed developing and using advanced imaging to pursue her own research and began the hunt for a faculty post. But it was right during a US economic downturn. Interviews took place but universities followed up to notify her that, as a result of the downturn, they could not hire after all. “I didn’t lose hope, though,” she says. Her multi-disciplinary background seemed a blemish. Even in an age that prizes interdisciplinary projects, she heard reactions in the vein of: “You’re not really a chemist or you’re not really a biologist,” she says. “It was just really hard to feel like I belonged in a department.” That changed when she started applying for posts in biomedical engineering. Universities liked her background in chemistry, physics, biology and computing.

Despite other offers, she decided to stay in Irvine, where she had already found collaborators. Staying would accelerate her ability to set up her lab, she says, and help her students “hit the ground running.” In her first year as principal investigator, she had five Ph.D. students. She welcomes people into her lab from diverse training backgrounds.

From this diverse lab now comes Mitometer: software to automate the way mitochondria are segmented and tracked in live-cell imaging and to avoid needing to piece together a computational pipeline of several tools. Digman is happy that Mitometer can capture the structure and size of mitochondria, count fission and fusion events, continuously track mitochondria, and capture their motility and velocity. Such information can be connected to metabolic data.

Mitochondria give scientists a workout. “Sometimes mitochondria can get clustered in one particular spot,” she says, which gets in the way of accurate counting. “If you want to count them, the algorithms will just count the blob as one gigantic spot.” Austin Lefebvre, a Ph.D. student in Digman’s lab, worked out a way to apply fluorescence intensity thresholds to remove image noise. The software loops through images to computationally locate the mitochondria. The team applied Mitometer to synthetic data and then to confocal images of breast cancer cells and found that cancerous and non-cancerous cells differed in motility and morphology. They connected that information to metabolic differences found using fluorescence lifetime imaging. Tumor cells and non-tumor cells differ in the free and bound ratio of the coenzyme NADH, which is important in cellular energy production. This hints at potential ways to target mitochondria for therapeutic purposes.

Of her future plans, Digman says, “We would like to use Mitometer a lot more.” And she hopes it can be used in other labs. Neuroscientists could use it to track mitochondrial journeys in long axons, she says. After collecting a time-lapse image series and setting some parameters, labs should find the system easy to use. “Austin has made this platform, let’s say, anyone-proof.”

Anyone should also be able to enter science, which is why she has set up, in her lab, a summer week for local community college and high school students from groups under-represented in science. Observing the students, Digman says, “I think they are really transformed.” Their tasks relate to work in her and other UCI labs. For example, they have explored using fluorescence lifetime imaging to detect how macrophage types differ in terms of metabolism.

Beyond these activities, Digman practices the martial art of iaido, an ancient samurai-sword-drawing technique from Japan. The movements are intended to look and feel effortless. “It’s almost a meditative art form for me,” she says. Iaido is a way to develop strength and to practice a traditional martial art. “The purpose is to display an ultimate level of true and pure beauty.”

Says cell biologist Rick Horwitz, “Michelle has this extraordinary ability to bridge complex biophysical technologies with cutting edge biological problems.” Digman spent part of her postdoctoral fellowship in his lab at the University of Illinois. Others attempt such bridges without understanding the methods, or they marry methods with mundane biological problems or fail to grasp nuances of experimental cell and molecular biology, says Horwitz who is senior advisor and inaugural executive director emeritus of the Allen Institute for Cell Science.

Digman has “the magic” to make projects happen and the collaborative spirit to bring community with her, he says. “Unlike some outstanding scientists, Michelle is a wonderful colleague—generous, helpful, collaborative, a real team player, and liked by everyone.”

Click here to read the full article on the UCI Samueli School of Engineering website.

In Memoriam: Distinguished Professor Emeritus Michael Berns

By Lori Brandt, UCI Samueli School of Engineering

Michael Berns, UC Irvine Distinguished Professor Emeritus of Surgery and Biomedical Engineering, died at his home in Irvine on Saturday, Aug. 13, 2022. The founding director of the UCI Beckman Laser Institute and Medical Clinic served on the UCI faculty for nearly half a century.

Berns earned his undergraduate and graduate degrees from Cornell University in 1964 and 1968, respectively. He came to UCI from the University of Michigan in 1973. He served as chair of the Department of Developmental and Cell Biology within the School of Biological Sciences, and also held appointments in the School of Medicine and Samueli School of Engineering. Berns co-founded, with Arnold Beckman, the Beckman Laser Institute and Medical Clinic in 1982 and served as its director until 2003. He was the Arnold and Mabel Beckman Professor from 1988-2020. Berns also founded the first Laser Microbeam Program and the UCI Photonic Incubator.

According to biomedical engineering department Chair Zoran Nenadic, in an email to the department staff and faculty, “Although a cell biologist by training, Michael was keenly aware that modern biological discoveries would be increasingly reliant on technological solutions. When Dr. Arnold Beckman showed up at Michael’s lab on a rainy morning four decades ago, he was fascinated by Michael’s work on laser microscopy and immediately recognized its potential. His endowment led to the creation of the world-renowned Beckman Laser Institute.”

Berns was also instrumental in pursuing the formation of UCI’s BME department. “Since a great deal of his work was in engineering and there was no bioengineering department at UCI, Michael, together with Bruce Tromberg and Steve George, had a vision to create one,” wrote Nenadic. “In 1998, they applied to the Whitaker Foundation Development Award, which was responsible for seeding many bioengineering/biomedical engineering departments nationwide. While easily the least developed program at the time, this group of enthusiasts shocked the BME world by winning the award. Michael, who was the principal investigator on the proposal, and the research infrastructure that he had built at the BLI were instrumental in persuading the reviewers.”

Berns’ pioneering work focused on the use of laser technology in medical and biological research. He developed tools and techniques for the surgical use of lasers, down to the level of manipulating single cells and individual chromosomes. He published extensively on the use of lasers in both biomedical research and medical treatment of illnesses, including skin disorders, vascular disease, eye problems and cancer.

He was an elected fellow/member in numerous scientific and engineering societies, including the Royal Society of Biology of Great Britain, the Academy of the Royal Norwegian Academy of Sciences and Letters, the American Association for the Advancement of Science, the American Institute for Medical and Biological Engineering, and the American Society for Laser Medicine and Surgery. Most recently, Berns was recognized by the International Society for Optics and Photonics with the 2022 SPIE Gold Medal. In 1994, he was awarded the UCI Medal – the highest award at UCI for outstanding career achievements.

His scientific achievements were numerous and impactful. His work has been cited over 26,000 times, spanning the fields of developmental biology, DNA repair, mechanobiology, the cytoskeleton, fertility, preservation of endangered species and immunology, to name just a few.

Berns mentored former BLI director and current National Institute of Biomedical Imaging and Bioengineering Director Bruce Tromberg, as well as several UCI professors, including Vasan Venugopalan, Elliot Botvinick and Daryl Preece. “He artfully blended strong leadership with kindness, care and generosity toward budding scientists of all ages,” said Nenadic. “He will be dearly missed.”

Said UCI Chancellor Howard Gillman, in a message to the campus community, “Michael Berns will be greatly missed by his friends and professional colleagues around the world. The entire university community joins me in sending condolences to his devoted children, Greg and Tammy.”

Read the full article on the UCI Samueli School of Engineering website.

eLysis Uses Saline and Electricity to Get that Perfect Look

By: Ethan Perez

Photo by: UCI Beall Applied Innovation

Body sculpting or contouring — or procedures in which excess body fat from specific areas is removed to achieve a patient’s desired appearance — have become increasingly popular cosmetic procedures sought by patients. Data gathered by Statista showed there were over 600,000 body sculpting procedures performed in the U.S. in 2018 alone. Procedures to remove fat from specific areas can involve nonsurgical freezing or heating, surgical removal or the injection of an acid into the desired area.

One UCI startup is prepared to shock the industry with a new minimally invasive approach to achieve precision body contouring results with little more than a saline solution and an electric current.

IT’S ELECTRIC
After receiving his Ph.D. in Biomedical Engineering from UC Irvine’s (UCI) Henry Samueli School of Engineering, Joon You, Ph.D., became interested in starting companies. He co-founded the optical imaging company that would become Modulim — a UCI startup — and has co-founded several startups since.

One such project had You working with longtime collaborator Dr. Brian Wong, a facial plastic surgeon at the UCI Medical Center and faculty at the School of Medicine and the School of Engineering, developing a technology from Wong’s lab. Dr. Wong’s research centered around using electrochemistry to alter living tissues.

The use of electrochemistry to alter living tissue was discovered by accident by Wong and his post-doctoral fellow at the time, Sergio Diaz-Valdez. Through what can only be described as a happy accident caused by a mix-up when setting up the circuitry, the procedure did not produce heat through radiofrequency energy but still happened to elicit the same desired result.

“It was a mystery,” said You, “But the only explanation was electrochemistry, because of the low voltage and small current.”

The potential market for a device that reshapes cartilage through electrochemistry — or a chemical reaction created by electricity — was relatively small, so the team looked elsewhere across many potential applications in medicine.

Because the technology could be easily tuned to dissolve fat, the team believed it could be used for body contouring procedures as an alternative to the more costly and more invasive surgical procedures.

“Originally, we were not sure if we were ready to start another company, but decided to give it a try,” said You. “We were then able to get proof of concept funding from Beall Applied Innovation and that really helped us get to our first animal study, which can be very expensive and difficult to get funding for at that stage.”

With help from the Proof of Product (POP) Grant-funded animal study, eLysis demonstrated that the technology can achieve precision body contouring results by giving pigs the appearance of six-pack abs.

With that, eLysis Inc. was established and co-founded by You, chief technology officer and interim CEO; Wong; Michael Hill, Ph.D., a professor of Chemistry at Occidental College; and Dr. Steve Yoelin, an ophthalmologist and developer of Latisse, the pharmaceutical treatment for growing eyelashes.

Click here to read the full article on the UCI Beall Applied Innovation website.

Virgin Orbit Successfully Launches 7 Satellites In 3rd Mission

By: Lia De La Cruz

Photo by: The Verge

Liftoff! June 30, 2021

Virgin Orbit celebrated the success of its third-ever space mission on June 30, 2021. The successful launch carried seven satellites to their target orbits. The company’s air-launched rocket, LauncherOne, took off from the Mojave Air and Space Port in Southern California beneath the wing of its Boeing 747 carrier plane, also known as Cosmic Girl. Liftoff came at 9:50 a.m. EDT (13:50 UTC), and the rocket deployed high above the Pacific Ocean almost an hour later at 10:47 a.m. (14:47 UTC). Virgin Orbit announced via Twitter that all seven payloads had successfully reached their target orbits shortly afterwards.

LauncherOne is a 70-foot-long (21-m-long) two-stage rocket, capable of delivering up to 1,100 pounds (500 kg) of freight to orbit. One feature unique to LauncherOne is its air-launch strategy, a method performed by separating from Cosmic Girl at an altitude of roughly 35,000 feet (10,700 m) and thrusting into low-Earth orbit from that point. Virgin Orbit representatives claim that this method increases flexibility and responsiveness when compared to vertical launches, at least in the case of LauncherOne.

The company also employs this strategy with its space tourism plane, SpaceShipTwo.

The current target price for LauncherOne is below $10 million per flight and is expected to be joined by dozens of new launch vehicles manufactured by Virgin Orbit in the coming years. Numerous large global networks are in development by companies like SpaceXSITAEL, and the formerly-bankrupt OneWeb, looking to connect us across vast distances, stimulate the global economy, and expand the limits of human knowledge: an industry Virgin Orbit is hoping to assist in.

Another customer is a subsidiary of Virgin Orbit called VOX Space, created in the early 2020s and intended to use the LauncherOne launch vehicle. The company plans to supply launch services for the U.S. military, sometimes referred to as the “national security launch market.” In April 2020, VOX Space was awarded a $35 million contract for three launches of 44 cubesats.

A different project Virgin Orbit took interest in was in response to the coronavirus pandemic in early 2020, when the company announced it would help build comparatively low-grade mechanical ventilators (breathing machines) to address the critical global shortage of mechanical ventilators. To develop and produce them, Virgin Orbit, the University of California, Irvine, and the University of Texas at Austin formed the Bridge Ventilator Consortium.

Click here to read the full article on the Earthsky website.